E. Sotaniemi, A. Arranto, O. Pelkonen, and M. Pasanen, Age and cytochrome P450-linked drug metabolism in humans: An analysis of 226 subjects with equal histopathologic conditions*, Clinical Pharmacology & Therapeutics, vol.22, issue.3, pp.331-340, 1997.
DOI : 10.1016/S0009-9236(97)90166-1

F. Péhourcq and M. Molimard, Pharmacocin??tique chez le sujet ??g??, Revue des Maladies Respiratoires, vol.21, issue.5, pp.356-62, 2002.
DOI : 10.1016/S0761-8425(04)71559-4

I. Maquin-mavier, Les études pharmacocinétiques et pharmacodynamiques chez le sujet âgé, apports et limites, janvier 2006, Disponible sur

M. Pancrazi, Le sujet ??g?? et les psychotropes, L'information psychiatrique, vol.86, issue.1, pp.91-98, 2010.
DOI : 10.3917/inpsy.8601.0091

K. Ellett, L. Pratt, N. Ramsay, E. Barratt, J. Roughead et al., Multiple Anticholinergic Medication Use and Risk of Hospital Admission for Confusion or Dementia, Journal of the American Geriatrics Society, vol.2012, issue.10, pp.1916-1938, 2014.
DOI : 10.1111/jgs.13054

D. Gnjidic, S. Hilmer, S. Hartikainen, A. Tolppanen, H. Taipale et al., Impact of High Risk Drug Use on Hospitalization and Mortality in Older People with and without Alzheimer???s Disease: A National Population Cohort Study, PLoS ONE, vol.44, issue.1, p.83224, 2014.
DOI : 10.1371/journal.pone.0083224.s001

F. Quevillon and M. Bédard, Benzodiazepinas: Conseq????ncias no funcionamento mn??sico das pessoas idosas, Sant?? mentale au Qu??bec, vol.28, issue.2, pp.23-41, 2003.
DOI : 10.7202/008615ar

H. Curran, R. Collins, S. Fletcher, S. Kee, B. Woods et al., Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life, Psychological Medicine, vol.33, issue.7, pp.1223-1260, 2003.
DOI : 10.1017/S0033291703008213

J. Puustinen, R. Lähteenmäki, P. Polo-kantola, P. Salo, T. Vahlberg et al., Effect of withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotic agents on cognition in older adults, European Journal of Clinical Pharmacology, vol.49, issue.2, pp.319-348, 2014.
DOI : 10.1007/s00228-013-1613-6

M. Barker, K. Greenwood, M. Jackson, and S. Crowe, An evaluation of persisting cognitive effects after withdrawal from long-term benzodiazepine use, Journal of the International Neuropsychological Society, vol.24, issue.4, pp.281-290, 2005.
DOI : 10.1097/00004850-199409000-00002

M. Barker, K. Greenwood, M. Jackson, and S. Crowe, Cognitive Effects of Long-Term Benzodiazepine Use, CNS Drugs, vol.29, issue.1, pp.37-48, 2004.
DOI : 10.2165/00023210-200418010-00004

J. Glass, K. Lanctôt, N. Herrmann, B. Sproule, and U. Busto, Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits, BMJ, vol.331, issue.7526, p.1169, 2005.
DOI : 10.1136/bmj.38623.768588.47

H. Verdoux, R. Lagnaoui, and B. Begaud, Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies, Psychological Medicine, vol.35, issue.3, pp.307-322, 2005.
DOI : 10.1017/S0033291704003897

A. Couderc, C. Bailly-agaledes, J. Camalet, F. Capriz-ribière, A. Gary et al., Adaptations of psychotropic drugs in patients aged 75 years and older in a departement of geriatric internal medecine: report of 100 cases], Gériatrie Psychol Neuropsychiatr Vieil. juin, vol.9, issue.2, pp.163-70, 2011.

C. Nationale and D. Pharmacovigilance, Compte rendu de la réunion du mardi 25 mars 2008 -bd7be64de27e31df5c8182983443353f.pdf [Internet]. [cité 27 avr 2015, Disponible sur

C. Mannesse, F. Derkx, M. De-ridder, M. Veld, A. Van-der-cammen et al., Adverse drug reactions in elderly patients as contributing factor for hospital admission: cross sectional study, BMJ, vol.315, issue.7115, pp.1057-1065, 1997.
DOI : 10.1136/bmj.315.7115.1057

K. Sikdar, J. Dowden, R. Alaghehbandan, D. Macdonald, P. Peter et al., Adverse Drug Reactions in Elderly Hospitalized Patients: A 12-Year Population-Based Retrospective Cohort Study, Annals of Pharmacotherapy, vol.182, issue.7-8, pp.7-8960, 2012.
DOI : 10.1016/j.jclinepi.2007.08.003

J. Stausberg, International prevalence of adverse drug events in hospitals: an analysis of routine data from England, Germany, and the USA, BMC Health Services Research, vol.266, issue.1, p.125, 2014.
DOI : 10.1001/jama.1991.03470200059035

A. Phillips, O. Nigro, K. Macolino, K. Scarborough, C. Doecke et al., Hospital admissions caused by adverse drug events: an Australian prospective study, Australian Health Review, vol.38, issue.1, pp.51-58, 2014.
DOI : 10.1071/AH12027

J. Ma, Y. Wang, M. Gao, Q. Meng, and J. Liu, Adverse drug reactions as the cause of emergency department admission of patients aged 80years and older, European Journal of Internal Medicine, vol.23, issue.6, pp.162-165, 2012.
DOI : 10.1016/j.ejim.2012.05.004

M. Franceschi, C. Scarcelli, V. Niro, D. Seripa, A. Pazienza et al., Prevalence, Clinical Features and Avoidability of Adverse Drug Reactions as Cause of Admission to??a??Geriatric Unit, Drug Safety, vol.12, issue.6, pp.545-56, 2008.
DOI : 10.2165/00002018-200831060-00009

D. Budnitz, M. Lovegrove, N. Shehab, and C. Richards, Emergency Hospitalizations for Adverse Drug Events in Older Americans, New England Journal of Medicine, vol.365, issue.21, pp.2002-2014, 2011.
DOI : 10.1056/NEJMsa1103053

C. Mclachlan, M. Yi, A. Ling, and D. Jardine, Adverse drug events are a major cause of acute medical admission, Internal Medicine Journal, vol.40, issue.7, pp.633-641, 2014.
DOI : 10.1111/imj.12455

P. De-paepe, M. Petrovic, L. Outtier, G. Van-maele, and W. Buylaert, DRUG INTERACTIONS AND ADVERSE DRUG REACTIONS IN THE OLDER PATIENTS ADMITTED TO THE EMERGENCY DEPARTMENT, Acta Clinica Belgica, vol.68, issue.1, pp.15-21, 2013.
DOI : 10.2143/ACB.68.1.2062714

J. Gurwitz, T. Field, L. Harrold, J. Rothschild, K. Debellis et al., Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting, JAMA, vol.289, issue.9, pp.1107-1123, 2003.
DOI : 10.1001/jama.289.9.1107

G. Pattyn, Etude de l'incidence et de la prise en charge des effets indésirables des médicaments en médecine générale: thèse [Thèse d'exercice, 2003.

L. Briole and M. , Le patient, son médecin généraliste et l'effet indésirable médicamenteux: à propos de 153 cas de patients déclarant un effet indésirable médicamenteux [Thèse d'exercice] Faculté des sciences médicales Rangueil, 2009.

J. Lazarou, B. Pomeranz, and P. Corey, Incidence of Adverse Drug Reactions in Hospitalized Patients, JAMA, vol.279, issue.15, pp.1200-1205, 1998.
DOI : 10.1001/jama.279.15.1200

M. Kvasz, I. Allen, M. Gordon, E. Ro, R. Estok et al., Adverse drug reactions in hospitalized patients: A critique of a meta-analysis, MedGenMed Medscape Gen Med. 27 avr, vol.2, issue.2, p.3, 2000.

F. Ahern, L. Sahm, D. Lynch, and S. Mccarthy, Determining the frequency and preventability of adverse drug reaction-related admissions to an Irish University Hospital: a cross-sectional study, Emergency Medicine Journal, vol.27, issue.1, pp.24-33, 2014.
DOI : 10.1136/emermed-2012-201945

H. Beijer and C. De-blaey, Hospitalisations caused by adverse drug reactions (ADR): a metaanalysis of observational studies, Pharmacy World and Science, vol.24, issue.2, pp.46-54, 2002.
DOI : 10.1023/A:1015570104121

B. Bégaud, K. Martin, A. Fourrier, and F. Haramburu, Does age increase the risk of adverse drug reactions?, Br J Clin Pharmacol. nov, vol.54, issue.5, pp.550-552, 2002.

E. Davies, C. Green, D. Mottram, P. Rowe, and M. Pirmohamed, Emergency re-admissions to hospital due to adverse drug reactions within 1 year of the index admission, British Journal of Clinical Pharmacology, vol.301, issue.5, pp.749-55, 2010.
DOI : 10.1111/j.1365-2125.2010.03751.x

M. Pirmohamed, S. James, S. Meakin, C. Green, A. Scott et al., Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients, BMJ, vol.329, issue.7456, pp.15-24, 2004.
DOI : 10.1136/bmj.329.7456.15

J. Cooper, D. Love, and P. Raffoul, Intentional Prescription Nonadherence (Noncompliance) by the Elderly, Journal of the American Geriatrics Society, vol.92, issue.5, pp.329-362, 1982.
DOI : 10.1111/j.1532-5415.1982.tb05623.x

C. Hughes, Medication Non-Adherence in the Elderly, Drugs & Aging, vol.15, issue.12, pp.793-811, 2004.
DOI : 10.2165/00002512-200421120-00004

S. Lacaille and S. Legrain, Observance des traitements médicamenteux chez les sujets âgés Disponible sur

B. Lyon-g and M. M. =union-régionale, Commission Exercice en Cabinet Libéral. Paris. FRA / com. L'Observance thérapeutique des personnes de 70 ans et plus, p.60, 2005.

. Evaluation-de-la-connaissance and . Qu, ont les personnes âgées de leurs médicaments [Internet]. [cité 27 avr 2015]. Disponible sur: http://pepite-depot.univ- lille2, pp.1-6475

G. Bouvy, Critères influençant la connaissance des traitements chez les sujets âgés : étude prospective chez 200 patients. 16 févr 2012

M. Chung and J. Bartfield, Knowledge of prescription medications among elderly emergency department patients, Annals of Emergency Medicine, vol.39, issue.6, pp.605-613, 2002.
DOI : 10.1067/mem.2002.122853

B. Lepoutre, É. Cotassou, and P. Zerr, Renouvellement d'ordonnance chez la personne âgée. Le syndrome de la 5e ligne, Médecine. 1 nov, vol.4, issue.9, pp.411-416, 2008.

M. Schneider, J. Locca, O. Bugnon, and M. Conzelmann, [Drug compliance in the elderly: determinants and support]. Rev Médicale Suisse. 8 mars, pp.664-670, 2006.

S. Arlt, R. Lindner, A. Rösler, and W. Von-renteln-kruse, Adherence to Medication in Patients with Dementia, Drugs & Aging, vol.22, issue.4, pp.1033-1080, 2008.
DOI : 10.2165/0002512-200825120-00005

B. Briesacher, J. Gurwitz, and S. Soumerai, Patients At-Risk for Cost-Related Medication Nonadherence: A Review of the Literature, Journal of General Internal Medicine, vol.317, issue.part 2, pp.864-71, 2007.
DOI : 10.1007/s11606-007-0180-x

J. Piette, M. Heisler, S. Krein, and E. Kerr, The Role of Patient-Physician Trust in Moderating Medication Nonadherence Due to Cost Pressures, Archives of Internal Medicine, vol.165, issue.15, pp.1749-55, 2005.
DOI : 10.1001/archinte.165.15.1749

S. Vik, C. Maxwell, and D. Hogan, Measurement, Correlates, and Health Outcomes of Medication Adherence Among Seniors, Annals of Pharmacotherapy, vol.34, issue.2, pp.303-315, 2004.
DOI : 10.1037/0278-6133.3.4.385

V. Sehgal, S. Bajwa, R. Sehgal, A. Bajaj, U. Khaira et al., Polypharmacy and potentially inappropriate medication use as the precipitating factor in readmissions to the hospital, Journal of Family Medicine and Primary Care, vol.2, issue.2, pp.194-203, 2013.
DOI : 10.4103/2249-4863.117423

A. Frély, E. Chazard, A. Pansu, J. Beuscart, and F. Puisieux, Impact of acute geriatric care in elderly patients according to the Screening Tool of Older Persons' Prescriptions/Screening Tool to Alert doctors to Right Treatment criteria in northern France, Geriatrics & Gerontology International, vol.12, issue.Suppl 1, 2015.
DOI : 10.1111/ggi.12474

N. Salles-montaudon, A. Fourrier, J. Dartigues, M. Rainfray, and J. Emeriau, ??volution des traitements m??dicamenteux des personnes ??g??es vivant ?? domicile, La Revue de M??decine Interne, vol.21, issue.8, pp.664-71, 2000.
DOI : 10.1016/S0248-8663(00)80021-1

M. Runganga, N. Peel, and R. Hubbard, Multiple medication use in older patients in post-acute transitional care: a prospective cohort study, Clin Interv Aging. 2 sept, vol.9, pp.1453-62, 2014.

B. De-wazières, C. Carol, J. Vernaz, B. Ledesert, L. Pape et al., Analyse de la prescription m??dicamenteuse chez les plus de 65 ans en Languedoc-Roussillon, La Revue de M??decine Interne, vol.23, issue.9, pp.745-50, 2002.
DOI : 10.1016/S0248-8663(02)00670-7

. Le-risque-iatrogène-chez-la-personne-Âgée, à propos des médicaments potentiellement inappropriés -laroche-marie-laure.pdf [Internet], Disponible sur, 2015.

N. Foucher, B. Lahille, N. Bernard, S. Poutrel, S. Pedebosq et al., Influence of hospitalisation on the elderly people polypharmacy]. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, janv, vol.30, issue.1, pp.20-24, 2009.

M. De-meyere, Une polymédication inéluctable en EBM? [Internet], Disponible sur, 2015.

F. Montastruc, C. Duguet, V. Rousseau, H. Bagheri, and J. Montastruc, Potentially inappropriate medications and adverse drug reactions in the elderly: a study in a PharmacoVigilance database, European Journal of Clinical Pharmacology, vol.288, issue.9, pp.1123-1130, 2014.
DOI : 10.1007/s00228-014-1707-9

R. Galvin, F. Moriarty, G. Cousins, C. Cahir, N. Motterlini et al., Prevalence of potentially inappropriate prescribing and prescribing omissions in older Irish adults: findings from The Irish LongituDinal Study on Ageing study (TILDA), European Journal of Clinical Pharmacology, vol.59, issue.5, pp.599-606, 2014.
DOI : 10.1007/s00228-014-1651-8

J. Hamano and Y. Tokuda, Inappropriate Prescribing Among Elderly Home Care Patients in Japan, Journal of Primary Care & Community Health, vol.51, issue.2, pp.90-96, 2014.
DOI : 10.1016/j.jamda.2011.02.009

C. Cool, P. Cestac, C. Laborde, C. Lebaudy, L. Rouch et al., Potentially Inappropriate Drug Prescribing and Associated Factors in Nursing Homes, Journal of the American Medical Directors Association, vol.15, issue.11, pp.850-851, 2014.
DOI : 10.1016/j.jamda.2014.08.003

M. Beers, J. Ouslander, I. Rollingher, D. Reuben, J. Brooks et al., Explicit Criteria for Determining Inappropriate Medication Use in Nursing Home Residents, Archives of Internal Medicine, vol.151, issue.9, pp.1825-1857, 1991.
DOI : 10.1001/archinte.1991.00400090107019

D. Fick, J. Cooper, W. Wade, J. Waller, J. Maclean et al., Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults, Archives of Internal Medicine, vol.163, issue.22, pp.2716-2740, 2003.
DOI : 10.1001/archinte.163.22.2716

M. Laroche, J. Charmes, and M. L. , Potentially inappropriate medications in the elderly: a French consensus panel list, European Journal of Clinical Pharmacology, vol.23, issue.8, pp.725-756, 2007.
DOI : 10.1007/s00228-007-0324-2

M. Laroche, F. Bouthier, M. L. Charmes, and J. , M??dicaments potentiellement inappropri??s aux personnes ??g??es??: int??r??t d???une liste adapt??e ?? la pratique m??dicale fran??aise, La Revue de M??decine Interne, vol.30, issue.7, pp.592-601, 2009.
DOI : 10.1016/j.revmed.2008.08.010

. Le-risque-iatrogène-chez-la-personne-Âgée, à propos des médicaments potentiellement inappropriés -laroche-marie-laure.pdf [Internet], Disponible sur, 2015.

P. Gallagher, C. Ryan, S. Byrne, J. Kennedy, O. Mahony et al., STOPP (Screening Tool of Older Person??s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation, Int. Journal of Clinical Pharmacology and Therapeutics, vol.46, issue.02, pp.72-83, 2008.
DOI : 10.5414/CPP46072

P. Gallagher, O. Mahony, and D. Stopp, STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria, Age and Ageing, vol.37, issue.6
DOI : 10.1093/ageing/afn197

A. Ubeda, L. Ferrándiz, N. Maicas, C. Gomez, M. Bonet et al., Potentially inappropriate prescribing in institutionalised older patients in Spain: the STOPP-START criteria compared with the Beers criteria, Pharmacy Practice (Internet), vol.10, issue.2, pp.83-91, 2012.
DOI : 10.4321/S1886-36552012000200004

L. Sánchez-muñoz, Inappropriate medication use in the elderly. Beers or STOPP-START criteria?]. Farm Hosp Órgano Of Expr Científica Soc Esp Farm Hosp, déc, vol.36, issue.6, pp.562-565, 2012.

D. Corsonello, G. Onder, A. Abbatecola, E. Guffanti, P. Gareri et al., Explicit Criteria for Potentially Inappropriate Medications to Reduce the Risk of Adverse Drug Reactions in Elderly People, Drug Safety, vol.26, issue.Suppl.1, pp.21-29, 2013.
DOI : 10.1007/BF03319100

J. Beuscart, C. Dupont, M. Defebvre, and F. Puisieux, Potentially inappropriate medications (PIMs) and anticholinergic levels in the elderly: A population based study in a French region, Archives of Gerontology and Geriatrics, vol.59, issue.3, pp.630-635, 2014.
DOI : 10.1016/j.archger.2014.08.006

L. Morin, J. Fastbom, M. Laroche, and K. Johnell, Potentially inappropriate drug use in older people: a nationwide comparison of different explicit criteria for population-based estimates, British Journal of Clinical Pharmacology, vol.5, issue.30
DOI : 10.1111/bcp.12615

URL : https://hal.archives-ouvertes.fr/hal-01141365

V. Kova?evi?, S. Simi?i?, M. , S. Rudinski, S. ?ulafi? et al., Potentially Inappropriate Prescribing in Older Primary Care Patients, PLoS ONE, vol.28, issue.4, p.95536, 2014.
DOI : 10.1371/journal.pone.0095536.t004

D. Sevilla-sánchez, J. Espaulella-panicot, A. De-andrés-lazaro, R. Torres-allezpuz, M. Soldevila-llagostera et al., Medicaci??n potencialmente inapropiada al ingreso en una unidad de media estancia seg??n los criterios STOPP & START, Revista Espa??ola de Geriatr??a y Gerontolog??a, vol.47, issue.4, pp.155-162, 2012.
DOI : 10.1016/j.regg.2012.02.013

P. López, N. , V. Villán, Y. , G. Menéndez et al., Potentially inappropriate prescribing in patients over 65 years-old in a primary care health centre

M. Yayla, U. Bilge, E. Binen, and A. Keskin, The Use of START/STOPP Criteria for Elderly Patients in Primary Care, The Scientific World Journal, vol.6, issue.4, p.165873, 2013.
DOI : 10.1093/ndt/gfl399

C. Ryan, O. Mahony, D. , O. Donovan, D. et al., A comparison of the application of STOPP/START to patients??? drug lists with and without clinical information, International Journal of Clinical Pharmacy, vol.65, issue.22, pp.230-235, 2013.
DOI : 10.1007/s11096-012-9733-0

B. Gage, E. Birman-deych, R. Kerzner, M. Radford, D. Nilasena et al., Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall, The American Journal of Medicine, vol.118, issue.6, pp.612-619, 2005.
DOI : 10.1016/j.amjmed.2005.02.022

R. Wright, R. Sloane, C. Pieper, C. Ruby-scelsi, J. Twersky et al., Underuse of indicated medications among physically frail older US veterans at the time of hospital discharge: Results of a cross-sectional analysis of data from the Geriatric Evaluation and Management Drug Study, The American Journal of Geriatric Pharmacotherapy, vol.7, issue.5, pp.271-80, 2009.
DOI : 10.1016/j.amjopharm.2009.11.002

M. Andro, S. Estivin, and A. Gentric, Prescriptions m??dicamenteuses en g??riatrie??: overuse (sur-utilisation), misuse (mauvaise utilisation), underuse (sous-utilisation). Analyse qualitative ?? partir des ordonnances de 200??patients entrant dans un service de court s??jour g??riatrique, La Revue de M??decine Interne, vol.33, issue.3, pp.122-129, 2012.
DOI : 10.1016/j.revmed.2011.11.016

O. Dalleur, A. Spinewine, S. Henrard, C. Losseau, N. Speybroeck et al., Inappropriate Prescribing and Related Hospital Admissions in Frail Older Persons According to the STOPP and START Criteria, Drugs & Aging, vol.49, issue.2, pp.829-866, 2012.
DOI : 10.1007/s40266-012-0016-1

E. Martínez-almazán, C. Castellà, N. Albiol, C. Cárdenas, J. Sánchez-rodríguez et al., Drug Prescription Suitability: Application of the Screening Tool of Older Persons??? Prescriptions/Screening Tool to Alert to Right Treatment (STOPP/START) Criteria in a Day-Care Geriatric Hospital, Journal of the American Geriatrics Society, vol.27, issue.60, pp.1622-1626, 2013.
DOI : 10.1111/jgs.12432

U. Gillespie, A. Alassaad, M. Hammarlund-udenaes, C. Mörlin, D. Henrohn et al., Effects of Pharmacists' Interventions on Appropriateness of Prescribing and Evaluation of the Instruments' (MAI, STOPP and STARTs') Ability to Predict Hospitalization???Analyses from a Randomized Controlled Trial, PLoS ONE, vol.61, issue.1, p.62401, 2013.
DOI : 10.1371/journal.pone.0062401.t003

C. Mivielle, Amélioration de la prescription médicamenteuse en gériatrie : application d'outils d'aide à la prescription au Centre Hospitalier de la Région d'Annecy et stabilité de ces prescriptions en ambulatoire, 2011.

P. Gallagher, O. Connor, M. , O. Mahony, and D. , Prevention of Potentially Inappropriate Prescribing for Elderly Patients: A Randomized Controlled Trial Using STOPP/START Criteria, Clinical Pharmacology & Therapeutics, vol.42, issue.6, pp.845-54, 2011.
DOI : 10.1111/j.1532-5415.2006.00889.x

M. Charvet-cabaret, Optimiser la prescription médicale du sujet âgé en soins primaires : impact de l'utilisation de l'outil STOPP (Screening Tool of Older Person's Prescription) sur les prescriptions médicamenteuses inappropriées, 2012.

D. Frankenthal, Y. Lerman, E. Kalendaryev, and Y. Lerman, Intervention with the Screening Tool of Older Persons Potentially Inappropriate Prescriptions/Screening Tool to Alert Doctors to Right Treatment Criteria in Elderly Residents of a Chronic Geriatric Facility: A Randomized Clinical Trial, Journal of the American Geriatrics Society, vol.337, issue.9, pp.1658-65, 2014.
DOI : 10.1111/jgs.12993

O. Dalleur, B. Boland, C. Losseau, S. Henrard, D. Wouters et al., Reduction of Potentially Inappropriate Medications Using the STOPP Criteria in Frail Older Inpatients: A Randomised Controlled Study, Drugs & Aging, vol.8, issue.5, pp.291-299, 2014.
DOI : 10.1007/s40266-014-0157-5

M. Moulis-rivière, Conciliation médicamenteuse de sortie en gériatrie : impact de la transmission hôpital-ville d'un bilan médicamenteux sur le maintien des optimisations thérapeutiques, 2014.

I. Ponson and A. Pechu, Prescription drug in the elderly. Study of changes in treatment during a stay in 221 geriatric patients in the Lyon region], Rev Prat. nov, vol.63, issue.9, pp.1215-1236, 2013.

D. Frankenthal, Y. Lerman, and Y. Lerman, The impact of hospitalization on potentially inappropriate prescribing in an acute medical geriatric division, International Journal of Clinical Pharmacy, vol.38, issue.6, pp.60-67, 2014.
DOI : 10.1007/s11096-014-0040-9

O. Mahony, D. , O. Sullivan, D. Byrne, S. et al., STOPP/START criteria for potentially inappropriate prescribing in older people: version 2 [Internet]. [cité 17 mars, Disponible sur, 2015.

C. Chang, J. Chen, C. Wen, H. Kuo, I. Lu et al., Potentially inappropriate medications in geriatric outpatients with polypharmacy: application of six sets of published explicit criteria, British Journal of Clinical Pharmacology, vol.169, issue.3, pp.482-491, 2011.
DOI : 10.1111/j.1365-2125.2011.04010.x

C. Hepler and L. Strand, Opportunities and responsibilities in pharmaceutical care, Am J Hosp Pharm. mars, vol.47, issue.3, pp.533-576, 1990.

S. Verdoorn, H. Kwint, A. Faber, J. Gussekloo, and M. Bouvy, Majority of drug-related problems identified during medication review are not associated with STOPP/START criteria, European Journal of Clinical Pharmacology, vol.44, issue.10, pp.1255-62, 2015.
DOI : 10.1007/s00228-015-1908-x

J. Brugts, T. Yetgin, S. Hoeks, A. Gotto, J. Shepherd et al., The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials, BMJ, vol.338, issue.jun30 1, pp.2376-2376, 2009.
DOI : 10.1136/bmj.b2376

F. Taylor, K. Ward, T. Moore, M. Burke, D. Smith et al., Statins for the primary prevention of cardiovascular disease In: The Cochrane Collaboration, éditeur, Disponible sur, 2011.

M. Tonelli, A. Lloyd, F. Clement, J. Conly, D. Husereau et al., Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis, Canadian Medical Association Journal, vol.183, issue.16, pp.1189-202, 2011.
DOI : 10.1503/cmaj.101280

. Prescrire-tous-les-articles-en-une, Statines : se poser des questions en termes de morts et d'accidents cardiovasculaires évités, et pas seulement en termes de taux de cholestérol, 2013.

K. Vitamin, direct thrombin inhibitor or factor Xa inhibitors for first pulmonary embolus without continuing provoking risk factors (e.g. thrombophilia) for > 12 months (no proven added benefit)

. Anticholinergics, antimuscarinics in patients with delirium or dementia (risk of exacerbation of cognitive impairment

.. Lieu-de-vie, page 23 d) Diagnostics retenus en fin d'hospitalisation, p.23